Thus, GILZ inhibits transcription factors, such as NF-κB15 and AP-121, that are implicated in tumor-promoting functions27,28 and signaling pathways, such Ras-MEK-ERK, that are involved in pro-tumorigenic effects29. The gene discussed is TSC22D3; the disease is neoplasm.